BACKGROUND: If a validated questionnaire, when applied to patients reporting with symptoms of intermittent claudication, could adequately discriminate between those with and without peripheral arterial disease, GPs could avoid the diagnostic measurement of the ankle brachial index. AIM: To investigate the Edinburgh Claudication Questionnaire (ECQ) in general practice and to develop a clinical decision rule based on risk factors to enable GPs to easily assess the likelihood of peripheral arterial disease. DESIGN OF STUDY: An observational study. SETTING: General practice in The Netherlands. METHOD: This observational study included patients of > or =55 years visiting their GP for symptoms suggestive of intermittent claudication or with one risk factor. The ECQ and the ankle brachial index were performed. The prevalence of peripheral arterial disease, defined as an ankle brachial index <0.9, was related to risk factors using logistic regression analyses, on which a clinical decision rule was developed and related to the presence of peripheral arterial disease. RESULTS: Of the 4790 included patients visiting their GP with symptoms suggestive of intermittent claudication, 4527 were eligible for analyses. The prevalence of peripheral arterial disease in this group was 48.3%. The sensitivity of the ECQ was only 56.2%. The prevalence of peripheral arterial disease in a clinical decision rule that included age, male sex, smoking, hypertension, hypercholesterolemia, and a positive ECQ, increased from 14% in the lowest to 76% in the highest category. CONCLUSION: This study indicates that the ECQ alone has an inadequate diagnostic value in detecting patients with peripheral arterial disease. The ankle brachial index should be performed to diagnose peripheral arterial disease in patients with complaints suggestive of intermittent claudication, although our clinical decision rule could help to differentiate between extremely high and lower prevalence of peripheral arterial disease.
BACKGROUND: If a validated questionnaire, when applied to patients reporting with symptoms of intermittent claudication, could adequately discriminate between those with and without peripheral arterial disease, GPs could avoid the diagnostic measurement of the ankle brachial index. AIM: To investigate the Edinburgh Claudication Questionnaire (ECQ) in general practice and to develop a clinical decision rule based on risk factors to enable GPs to easily assess the likelihood of peripheral arterial disease. DESIGN OF STUDY: An observational study. SETTING: General practice in The Netherlands. METHOD: This observational study included patients of > or =55 years visiting their GP for symptoms suggestive of intermittent claudication or with one risk factor. The ECQ and the ankle brachial index were performed. The prevalence of peripheral arterial disease, defined as an ankle brachial index <0.9, was related to risk factors using logistic regression analyses, on which a clinical decision rule was developed and related to the presence of peripheral arterial disease. RESULTS: Of the 4790 included patients visiting their GP with symptoms suggestive of intermittent claudication, 4527 were eligible for analyses. The prevalence of peripheral arterial disease in this group was 48.3%. The sensitivity of the ECQ was only 56.2%. The prevalence of peripheral arterial disease in a clinical decision rule that included age, male sex, smoking, hypertension, hypercholesterolemia, and a positive ECQ, increased from 14% in the lowest to 76% in the highest category. CONCLUSION: This study indicates that the ECQ alone has an inadequate diagnostic value in detecting patients with peripheral arterial disease. The ankle brachial index should be performed to diagnose peripheral arterial disease in patients with complaints suggestive of intermittent claudication, although our clinical decision rule could help to differentiate between extremely high and lower prevalence of peripheral arterial disease.
Authors: Mark A Creager; Jerry Goldstone; John W Hirshfeld; Andris Kazmers; K Craig Kent; Beverly H Lorell; Jeffrey W Olin; Rebecca Rainer Pauly; Kenneth Rosenfield; Gary S Roubin; Gregorio A Sicard; Christopher J White; Mark A Creager; William L Winters; John W Hirshfeld; Beverly H Lorell; Geno Merli; George P Rodgers; Cynthia M Tracy; Howard H Weitz Journal: J Am Coll Cardiol Date: 2004-08-18 Impact factor: 24.094
Authors: Z J Zheng; A R Sharrett; L E Chambless; W D Rosamond; F J Nieto; D S Sheps; A Dobs; G W Evans; G Heiss Journal: Atherosclerosis Date: 1997-05 Impact factor: 5.162
Authors: Hakan Demirtaş; Tuna Parpar; Bumin Değirmenci; Mustafa Kara; Ahmet Orhan Çelik; Ayşe Umul; Mustafa Kayan; Ömer Yılmaz Journal: Radiol Med Date: 2016-08-29 Impact factor: 3.469
Authors: María Teresa Alzamora; Rosa Forés; José Miguel Baena-Díez; Guillem Pera; Pere Toran; Marta Sorribes; Marisa Vicheto; María Dolores Reina; Amparo Sancho; Carlos Albaladejo; Judith Llussà Journal: BMC Public Health Date: 2010-01-27 Impact factor: 3.295
Authors: Saskia P A Nicolaï; Lotte M Kruidenier; Ellen V Rouwet; Marie-Louise E L Bartelink; Martin H Prins; Joep A W Teijink Journal: Br J Gen Pract Date: 2009-06 Impact factor: 5.386
Authors: Birgitta Sigvant; Fredrik Lundin; Bo Nilsson; David Bergqvist; Eric Wahlberg Journal: BMC Cardiovasc Disord Date: 2011-06-30 Impact factor: 2.298
Authors: Philip C Bennett; Gregory Y H Lip; Stanley Silverman; Andrew D Blann; Paramjit S Gill Journal: BMC Med Res Methodol Date: 2011-06-03 Impact factor: 4.615